Brokerages expect Alcentra Capital Corp. (NASDAQ:ABDC) to announce $8.81 million in sales for the current fiscal quarter, Zacks Investment Research reports. Six analysts have made estimates for Alcentra Capital Corp.’s earnings, with estimates ranging from $8.10 million to $9.35 million. Alcentra Capital Corp. reported sales of $9.12 million during the same quarter last year, which indicates a negative year over year growth rate of 3.4%. The firm is expected to issue its next quarterly earnings report on Thursday, November 2nd.

According to Zacks, analysts expect that Alcentra Capital Corp. will report full year sales of $8.81 million for the current financial year, with estimates ranging from $32.80 million to $37.19 million. For the next financial year, analysts forecast that the business will report sales of $38.51 million per share, with estimates ranging from $34.90 million to $40.12 million. Zacks’ sales averages are a mean average based on a survey of sell-side research firms that cover Alcentra Capital Corp..

Several research firms have weighed in on ABDC. Raymond James Financial, Inc. lowered shares of Alcentra Capital Corp. from a “strong-buy” rating to an “outperform” rating and decreased their target price for the company from $16.00 to $14.00 in a report on Monday, July 17th. DA Davidson began coverage on shares of Alcentra Capital Corp. in a report on Wednesday, July 5th. They issued a “buy” rating and a $15.00 target price on the stock. Keefe, Bruyette & Woods set a $14.00 target price on shares of Alcentra Capital Corp. and gave the company a “hold” rating in a report on Wednesday, May 31st. Finally, TheStreet lowered shares of Alcentra Capital Corp. from a “b” rating to a “c+” rating in a report on Monday, July 24th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and an average price target of $13.50.

In related news, Director Steven H. Reiff acquired 11,668 shares of the firm’s stock in a transaction dated Monday, August 7th. The shares were purchased at an average cost of $10.72 per share, for a total transaction of $125,080.96. Following the acquisition, the director now owns 7,000 shares in the company, valued at approximately $75,040. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Of New York Mellon Corp Bank sold 1,691,839 shares of the company’s stock in a transaction that occurred on Monday, May 22nd. The stock was sold at an average price of $13.13, for a total transaction of $22,213,846.07. The disclosure for this sale can be found here. Insiders own 4.96% of the company’s stock.

Several institutional investors have recently modified their holdings of the company. Bank of Montreal Can bought a new position in shares of Alcentra Capital Corp. during the second quarter valued at approximately $163,000. Oppenheimer & Co. Inc. raised its position in shares of Alcentra Capital Corp. by 4.4% in the second quarter. Oppenheimer & Co. Inc. now owns 13,098 shares of the asset manager’s stock valued at $178,000 after buying an additional 550 shares in the last quarter. Creative Planning raised its position in shares of Alcentra Capital Corp. by 2.9% in the first quarter. Creative Planning now owns 20,570 shares of the asset manager’s stock valued at $283,000 after buying an additional 570 shares in the last quarter. Wells Fargo & Company MN raised its position in shares of Alcentra Capital Corp. by 4.9% in the first quarter. Wells Fargo & Company MN now owns 28,835 shares of the asset manager’s stock valued at $396,000 after buying an additional 1,354 shares in the last quarter. Finally, Mackenzie Financial Corp bought a new position in shares of Alcentra Capital Corp. during the first quarter valued at approximately $491,000. Hedge funds and other institutional investors own 43.52% of the company’s stock.

Alcentra Capital Corp. (NASDAQ ABDC) opened at 10.74 on Friday. The firm’s 50 day moving average is $12.45 and its 200 day moving average is $13.12. Alcentra Capital Corp. has a 12-month low of $10.20 and a 12-month high of $14.73.

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 5th. Shareholders of record on Saturday, September 30th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.36 annualized dividend and a yield of 12.66%. Alcentra Capital Corp.’s payout ratio is -1,700.00%.

WARNING: “Zacks: Brokerages Expect Alcentra Capital Corp. (NASDAQ:ABDC) Will Post Quarterly Sales of $8.81 Million” was originally published by American Banking News and is the property of of American Banking News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.americanbankingnews.com/2017/08/12/zacks-brokerages-expect-alcentra-capital-corp-nasdaqabdc-will-post-quarterly-sales-of-8-81-million.html.

Alcentra Capital Corp. Company Profile

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Get a free copy of the Zacks research report on Alcentra Capital Corp. (ABDC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Alcentra Capital Corp. (NASDAQ:ABDC)

Receive News & Ratings for Alcentra Capital Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp. and related companies with MarketBeat.com's FREE daily email newsletter.